News

The objective of the phase I small business innovation research (SBIR) grant is to demonstrate the feasibility of using AvidBiotics’ proprietary technology to build customized antibacterial therapeutics, prophylactics

Results from the trial also show that patients who remained in the study and were on Copaxone had a relapse rate reduction of more than 80% over a

While vancomycin is highly potent against free living or planktonic MRSA bacteria, it is unable to eradicate the MRSA bacteria in the form of biofilms. In contrast, CSA-13

Endovasc has submitted its protocol for the phase IIIa clinical trial of the drug to the FDA, and hopes to initiate the trial later this year. Intermittent claudication,

Led by senior management from the advisors and consultants staff, within the Center for Drug Evaluation and Research (CDER), this examination of current practices will include the processes

The MHRA investigation allegedly comes after the charity Adverse Psychiatric Reactions Information Link (April) submitted a dossier of adverse event reports. According to April, there are hundreds of

Cytogen will no longer pay Berlex a royalty on Quadramet sales in exchange for an upfront cash payment of $6 million and the issuance of 623,441 shares of

Endo expects to file a supplemental new drug application with the FDA in the coming weeks to seek approval for the expanded indication. Frova is currently approved for

Paliperidone, which releases drug into the bloodstream steadily over a 24-hour period, is an extended release version of Johnson & Johnson’s blockbuster schizophrenia treatment Risperdal. The paliperidone filing